Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTPRC | P08575 | 5/20 | 0.66 |
| ▸ | S100A4 | P26447 | 2/20 | 0.66 |
| ▸ | CA9 | Q16790 | 2/20 | 0.59 |
| ▸ | CA12 | O43570 | 1/20 | 0.59 |
| ▸ | BCHE | P06276 | 1/20 | 0.58 |
| ▸ | ACHE | P22303 | 1/20 | 0.58 |
| ▸ | CES1 | P23141 | 1/20 | 0.58 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.58 |
| ▸ | TTR | P02766 | 1/20 | 0.57 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.56 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.56 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.56 |
| ▸ | TP53 | P04637 | 1/20 | 0.56 |
| ▸ | SRD5A2 | P31213 | 1/20 | 0.53 |
| ▸ | CA1 | P00915 | 1/20 | 0.53 |
| ▸ | CA2 | P00918 | 1/20 | 0.53 |
| ▸ | CA7 | P43166 | 1/20 | 0.53 |
| ▸ | MEN1 | O00255 | 1/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.50 |
| ▸ | ERO1A | Q96HE7 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30349970 | 0.84 | PTPRC (0.91) | PTPRCS100A4CA9BCHEACHE | |
| SCHEMBL1237207 | 0.84 | PTPRC (0.91) | PTPRCS100A4CA9BCHEACHE | |
| SCHEMBL11638272 | 0.84 | CHEK1 (0.52) | PTPRCS100A4CA9CA12TDP1 | |
| SCHEMBL600296 | 0.82 | TTR (0.80) | PTPRCTDP1TTRMEN1KMT2A | |
| SCHEMBL31086890 | 0.82 | TTR (0.80) | PTPRCTDP1TTRMEN1KMT2A | |
| SCHEMBL30412724 | 0.82 | TTR (0.64) | PTPRCTDP1TTRCYP1A2HIF1A | |
| SCHEMBL19302395 | 0.82 | TTR (0.64) | PTPRCTDP1TTRCYP1A2HIF1A | |
| SCHEMBL8104719 | 0.81 | PTPRC (0.84) | PTPRCS100A4CA9BCHEACHE | |
| SCHEMBL30375977 | 0.81 | PTPRC (0.84) | PTPRCS100A4CA9BCHEACHE | |
| SCHEMBL11632427 | 0.81 | CHEK1 (0.63) | PTPRCS100A4CA9CA12TDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11591294-B2 | Fluorenone/fluorenol derivatives for aqueous redox flow batteries | BATTELLE MEMORIAL INSTITUTE (US) | 2023-02-28 | — | — | US | claimed |
| US-20210147347-A1 | FLUORENONE/FLUORENOL DERIVATIVES FOR AQUEOUS REDOX FLOW BATTERIES | BATTELLE MEMORIAL INSTITUTE (US) | 2021-05-20 | — | — | US | claimed |
| EP-0147226-B1 | VISIBLE LIGHT ABSORBING PEROXY ESTERS | LOCTITE CORPORATION (US) | 1989-11-23 | — | — | EP | claimed |
| US-4604295-A | VISIBLE AND UV PHOTOINITIATORS FOR CURING ACRYLIC MONOMERS AND PREPOLYMERS | LOCTITE CORPORATION (US) | 1986-08-05 | — | — | US | claimed |
| EP-0147226-A2 | Visible light absorbing peroxy esters | LOCTITE CORPORATION (US) | 1985-07-03 | — | — | EP | claimed |
| US-11591294-B2 | Fluorenone/fluorenol derivatives for aqueous redox flow batteries | BATTELLE MEMORIAL INSTITUTE (US) | 2023-02-28 | — | — | US | disclosed |
| US-20210147347-A1 | FLUORENONE/FLUORENOL DERIVATIVES FOR AQUEOUS REDOX FLOW BATTERIES | BATTELLE MEMORIAL INSTITUTE (US) | 2021-05-20 | — | — | US | disclosed |
| EP-1091958-A1 | SALTS OF PAROXETINE | SMITHKLINE BEECHAM PLC (GB) | 2001-04-18 | — | — | EP | disclosed |
| WO-2000001692-A1 | SALTS OF PAROXETINE | SMITHKLINE BEECHAM PLC (GB) | 2000-01-13 | — | — | WO | disclosed |
| EP-0147226-B1 | VISIBLE LIGHT ABSORBING PEROXY ESTERS | LOCTITE CORPORATION (US) | 1989-11-23 | — | — | EP | disclosed |
| US-4604295-A | VISIBLE AND UV PHOTOINITIATORS FOR CURING ACRYLIC MONOMERS AND PREPOLYMERS | LOCTITE CORPORATION (US) | 1986-08-05 | — | — | US | disclosed |
| EP-0147226-A2 | Visible light absorbing peroxy esters | LOCTITE CORPORATION (US) | 1985-07-03 | — | — | EP | disclosed |
| US-3939276-A | ANTHRAQUINONES, ASTHMA, ANTIALLERGENS | BURROUGHS WELLCOME CO. (US) | 1976-02-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11591294-B2 | Fluorenone/fluorenol derivatives for aqueous redox flow batteries | NDUFV1, SCO2, NDUFS4 | PTPRC 3168/4885S100A4 390/4885CA9 892/4885 |
| US-20210147347-A1 | FLUORENONE/FLUORENOL DERIVATIVES FOR AQUEOUS REDOX FLOW BATTERIES | NDUFV1, SCO2, NDUFS4 | PTPRC 3168/4885S100A4 390/4885CA9 892/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.